Literature DB >> 20006145

A risk-benefit analysis of vaccination.

Ulrich Heininger1.   

Abstract

Impressive success has been achieved worldwide with population based immunisation programmes against several serious infectious diseases. This success is being threatened: the incidence of previously frequent, potentially devastating diseases decreases as a consequence of successful immunisation programmes and attention of the public shifts towards true and alleged "side effects" of vaccines. This can lead to the dilemma of waning public confidence in the necessity, tolerability and safety of vaccinations. Therefore, continuous evaluation of risks and benefits of vaccines is required and results of these need to be communicated broadly to strengthen the confidence in immunisation programmes.

Entities:  

Mesh:

Year:  2009        PMID: 20006145     DOI: 10.1016/j.vaccine.2009.10.010

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

Review 1.  Implementing clinical practice guidelines about health promotion and disease prevention through shared decision making.

Authors:  Mary C Politi; Kathleen Y Wolin; France Légaré
Journal:  J Gen Intern Med       Date:  2013-01-10       Impact factor: 5.128

2.  Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza.

Authors:  Nathalie Landry; Brian J Ward; Sonia Trépanier; Emanuele Montomoli; Michèle Dargis; Giulia Lapini; Louis-P Vézina
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

3.  Origins of injection-site sarcomas in cats: the possible role of chronic inflammation-a review.

Authors:  Kevin N Woodward
Journal:  ISRN Vet Sci       Date:  2011-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.